Costs of illness and health-related quality of life for community-acquired pneumonia a systematic review;Krankheitskosten sowie gesundheitsbezogene Lebensqualität (hrQoL) bei ambulant erworbener Pneumonie (CAP) ein systematisches Review

Pneumologie

Volumn 65, Issue 8, 2011, Pages 498-502

  Jacob, C ^a   Mittendorf, T ^a   Graf Von Der Schulenburg, J M ^b  

^a Herescon Gmbh   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY ACQUIRED PNEUMONIA; COST OF ILLNESS; GERMANY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; REFERENCE DATABASE; REVIEW; SYSTEMATIC REVIEW (TOPIC);

ACTIVITIES OF DAILY LIVING; ADULT; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; PNEUMONIA, BACTERIAL; QUALITY OF LIFE;

EID: 80051666190     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0030-1256353     Document Type: Review

References (28)

1. Höffken G, Lorenz J, Kern W et al. Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie Update 2009. Pneumologie 2009 63 e1-e68
2. CAPNETZ. CAP Definition und Epidemiologie. http://www.capnetz.de/html/ practitioners/cap/definition Stand: 3. Januar 2011
3. Bartolome M, Almirall J, Morera J et al. A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 2004 23 610-616 (Pubitemid 38456006)
4. Bauer T T., Welte T, Ernen C et al. Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 2005 128 2238-2246 (Pubitemid 41507565)
5. Birnbaum H G., Morley M, Greenberg P E. et al. Economic burden of pneumonia in an employed population. Arch Intern Med 2001 161 2725-2731 (Pubitemid 33134850)
6. Colice G L., Morley M A., Asche C et al. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004 125 2140-2145 (Pubitemid 38788182)
7. Estrada C A., Unterborn J N., Price J et al. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Effective Clinical Practice 2000 3 221-228
8. Frei C R., Burgess D. Community-acquired pneumonia: Objective criteria to predict severe disease. J Infect Dis Pharmacother 2004 6 39-48 (Pubitemid 40202395)
9. Guest J F., Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997 10 1530-1534 (Pubitemid 27311067)
10. Henderson A, Cleary M, Galbraith G et al. Prospective study of costs and outcome in a major adult Australian intensive care unit utilising the APACHE III severity scoring and prediction tool. Clinical Intensive Care 1997 8 58-62 (Pubitemid 27214180)
11. Kaplan V, Angus D C., Griffin M F. et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002 165 766-772 (Pubitemid 34229645)
12. Kruse R L., Boles K E., Mehr D R. et al. The cost of treating pneumonia in the nursing home setting. J Am Med Dir Assoc 2003 4 81-89 (Pubitemid 36336070)
13. Lave J R., Fine M J., Sankey S S. et al. Hospitalized pneumonia: Outcomes, treatment patterns, and costs in urban and rural areas. Journal of General Internal Medicine 1996 11 415-421 (Pubitemid 26286783)
14. Niederman M S., McCombs J S., Unger A N. et al. The cost of treating community-acquired pneumonia. Clin Ther 1998 20 820-837 (Pubitemid 28421502)
15. Orrick J J., Segal R, Johns T E. et al. Resource use and cost of care for patients hospitalised with community acquired pneumonia: Impact of adherence to Infectious Diseases Society of America guidelines. PharmacoEconomics 2004 22 751-757 (Pubitemid 38998499)
16. Paladino J A., Adelman M H., Schentag J J. et al. Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. PharmacoEconomics 2007 25 677-683 (Pubitemid 47124169)
17. Scott G, Scott H, Turley M et al. Economic cost of community-acquired pneumonia in New Zealand adults. New Zealand Medical Journal 2004 117 (1196) U933
18. Sun H K., Nicolau D P., Kuti J L. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae. Chest 2006 130 807-814 (Pubitemid 44423613)
19. Feagan B G. A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. Pharmacotherapy 2001 21 (7 Pt 2) 89S-94S
20. Palmer C S., Zhan C, Elixhauser A et al. Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin. Clinical Therapeutics 2000 22 250-264 (Pubitemid 30152104)
21. Marrie T J., Lau C Y., Wheeler S L. et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000 283 749-755
22. Carratala J F-S. Outpatient care compared with hospitalization for community-acquired pneumonia: A randomized trial in low-risk patients. Annals of Internal Medicine 2005 142 165-172
23. Fine M J., Auble T E., Yealy D M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997 336 243-250 (Pubitemid 27044625)
24. Ware J E., Kosinsky M, Keller S D. SF-36 Physical and Mental Health Summary Scales: A Users Manual. Boston Health Assessment Laboratory, New England Medical Center 1994
25. el Moussaoui R, Opmeer B C., de Borgie C A. et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest 2006 130 1165-1172 (Pubitemid 44583749)
26. el Moussaoui R, Opmeer B C., Bossuyt P M. et al. Development and validation of a short questionnaire in community acquired pneumonia. Thorax 2004 59 591-595 (Pubitemid 38901518)
27. Gleason P P., Kapoor W N., Stone R A. et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society Guidelines for outpatients with community-acquired pneumonia. Journal of the American Medical Association 1997 278 32-39 (Pubitemid 27274513)
28. Torres A, Muir J F., Corris P et al. Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. European Respiratory Journal 2003 21 135-143 (Pubitemid 36150313)